TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Microbiotech/se AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
264
|
235
|
310 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
21
|
2
|
-6 |
| EBITDA |
20
|
2
|
-6 |
| Total assets |
195
|
198
|
246 |
| Current assets |
195
|
198
|
246 |
| Current liabilities |
23
|
35
|
67 |
| Equity capital |
165
|
154
|
168 |
| - share capital |
28
|
29
|
32 |
| Employees (average) |
4
|
3
|
4 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
84.6%
|
77.8%
|
68.3% |
| Turnover per employee |
66
|
78
|
78 |
| Profit as a percentage of turnover |
8.0%
|
0.9%
|
-1.9% |
| Return on assets (ROA) |
10.8%
|
1.0%
|
-2.4% |
| Current ratio |
847.8%
|
565.7%
|
367.2% |
| Return on equity (ROE) |
12.7%
|
1.3%
|
-3.6% |
| Change turnover |
38
|
-47
|
64 |
| Change turnover % |
17%
|
-17%
|
26% |
| Chg. No. of employees |
1
|
-1
|
4 |
| Chg. No. of employees % |
33%
|
-25% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.